CVR 34585334Private limited company (ApS)Ikke-finansielle holdingselskaber (642120)København ØFounded 20 May 2012
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Aros Healthtech Investment ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
0
CVR, 2017
Gross profit
-13.3K
DKK, annual report 2025
Result
-236.6K
DKK, annual report 2025
Equity
16.9M
DKK, annual report 2025
Morten Aabo-Rosendal100% of capital and votes
Personal holding company
Dandex estimate: NACE 642120, controlled by a personMorten Aabo-Rosendalsince 20 May 2012
Owners of 5% or more. CVR registers shares in bands, not exact figures.
100% of capital and votessince 20 May 2012
1 Danish company.
SubsidiaryCVR 45349942100% of capital and votes
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR. Subsidiary (datterselskab): 50% or more of the votes, a Dandex estimate; in the 50% band a joint venture is not ruled out.
CVR 37086029100% of capital and votes11 Sep 2015 to 13 Jun 2025
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Jan 2017, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | May 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Jan 2017, published 30 Mar 2017.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit -13.3K, Operating profit -13.3K, Result for the year -236.6K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 17.2M, Equity 16.9M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -7 | -8 | -9 | -14 | -13 |
| Operating profit | -7 | -8 | -9 | -14 | -13 |
| Result for the year | +2,063 | +1,063 | +1,401 | +8,006 | -237 |
| Equity | 6,843 | 7,821 | 9,148 | 17,154 | 16,917 |
| Total assets | 8,796 | 10,333 | 10,569 | 18,951 | 17,250 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 0 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Aros Healthtech Investment ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 80,000 | None | 80,000 | None | 80,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
9 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 10.12.2025
Nyt navn: Aros Healthtech Investment ApS
Formål ændret: Selskabets formål er at virke som holdingselskab, herunder at eje kapitalandele i selskaber med primært investeringsfokus på Health Tech og Life Science, samt formuepleje og anden dermed beslægtet investeringsvirksomhed.
Ny adresse: Øster Allé 16, 2100 København Ø
Revision:
Fratrådte:
PIASTER REVISORERNE, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 26.05.2020.
Vedtægter ændret: 26.05.2020
Ny adresse: Amagertorv 16, 3., 1160 København K
Ny adresse: Østbanegade 7, st. th., 2100 København Ø
Ny kommune: København
CVR-nummer:
34585334.
NAVN:
AABO INVEST ApS.
Adresse: Fortunvej 38, 2920 Charlottenlund.
Kommune: Gentofte.
Ny adresse: Hyldegårds Tværvej 49, 3. tv., 2920 Charlottenlund
Ny kommune: Gentofte
Revision:
Udtrådt af revisionen:
BEIERHOLM, STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 03.06.2014.
Indtrådt i revisionen:
CVR-NR. 25160037 PIASTER REVISORERNE, STATSAUTORISERET REVISIONSAKTIESELSKAB, Abildgårdsparken 8A, 3460 Birkerød, den 03.06.2014.
Stiftelsesdato:
20.05.2012.
Seneste vedtægtsdato:
20.05.2012.
Kapital:
kr. 80.000,00.
Indbetalingsmåde:
Indbetalt kontant kr. 80.000,00 til kurs 100,00.
Stifter:
Morten Aabo, den 20.05.2012.
Direktion:
Morten Aabo, den 20.05.2012.
Selskabet tegnes af en direktør alene.
Revision:
BEIERHOLM, STATSAUTORISERET REVISIONSPARTNERSELSKAB, Gribskovvej 2, 2100 København Ø, den 20.05.2012.
Første regnskabsår:
20.05.2012 - 31.12.2012.
Regnskabsår:
01.01 - 31.12.
P-number 1017703877Øster Allé 16, 2100 København Ø